CIBC Bancorp USA’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09B Buy
906,485
+1,825
+0.2% +$1.86M 1.32% 10
2026
Q1
$832M Buy
+904,660
New +$917M 1.12% 12
2025
Q3
$84M Buy
+110,064
New +$81.9M 0.46% 36

Other funds holding LLY

CIBC Bancorp USA's LLY Position: Q2 2026 in Review

CIBC Bancorp USA increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $1.86M and bringing the position to 906,485 shares worth $1.09B. The position accounts for 1.32% of the portfolio, ranked #10.

CIBC Bancorp USA first reported a position in LLY in Q3 2025 and has held it in 3 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CIBC Bancorp USA held 906,485 shares of Eli Lilly worth $1.09B as of Q2 2026.
  • CIBC Bancorp USA bought 1,825 Eli Lilly shares in Q2 2026, an estimated $1.86M.
  • Eli Lilly made up 1.32% of CIBC Bancorp USA's portfolio in Q2 2026, its #10 holding.
  • CIBC Bancorp USA first reported a position in Eli Lilly in Q3 2025 and has held it in 3 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.